As 2019 comes to an end, we reflect on a year of hope and growth, with immense gratitude for our community. In 2020 we will continue to focus on helping people with...

New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...

En el Mes Nacional de la Salud de las Minorías, el autor comparte la historia de su diagnóstico de diabetes tipo 2

In-person visits, lab tests, and finger stick documentation are no longer required at present to get a CGM

Major milestones in 2019 brought time in range to the forefront of diabetes care

The diaTribe team was on the ground in Madrid, Spain to cover the latest news in diabetes technology from ATTD. Here are our top highlights from the conference!

The ADA Scientific Sessions starts later this week – we've highlighted some of the most important presentations and posters for you to look forward to

In exciting news, Tandem announced expanded clearance for the hybrid closed loop Control-IQ. The system is now available for children ages 6-13

The Time in Range Coalition aims to help millions of people by promoting time in range in diabetes care

The G6 Pro includes several exciting new features and is expected to start shipping next week!

Mark Harmel, MPH, CDCES, discusses how his clinic is moving to telemedicine in the time of COVID-19 and how to share data from many diabetes devices

dQ&A surveyed 2,540 CGM users with type 1 or type 2 diabetes to find out how aware they are of their own time in range: 87% of respondents knew how much time they...

Dr. Anne Peters shares insights on how healthcare professionals can help people ease the challenges of managing diabetes during COVID and how the shift to telemedicine...

We interviewed Dr. Partha Kar to learn about how people are using time in range in his clinic and what obstacles our society will need to overcome to promote wider use...

Rybelsus, a GLP-1 agonist pill already approved in Europe and the US, has just been approved by Health Canada for adults with type 2 diabetes

Health Canada authorizes the latest temporary approval for CGM during the pandemic: the Dexcom G6 is now available to pregnant women with diabetes

Expert physicians share a few of the benefits of virtual appointments for people living with diabetes

Enroll in Level2 to get a CGM, a Fitbit activity tracker, and easily accessible virtual health coaching; the program is designed to help people achieve type 2 diabetes...

Dive into AGP if you haven’t already! In our third video on understanding your ambulatory glucose profile (AGP) report, Dr. Carlson from the International Diabetes...

Though A1C has long been used as the primary metric for evaluating someone’s estimated average blood sugar, the glucose management indicator (GMI) is an alternative that...